INS and type 2 diabetes mellitus: Twice a day exenatide (5 vs 10 μg twice daily for 5 days) was shown to slow gastric emptying by scintigraphy in T2D in a dose-dependent manner, associated with a reduction in postmeal plasma glucose and peak insulin concentrations (23).